We are live on
!
Find out more
6CM
683 Capital Management Portfolio holdings
AUM
$1.92B
1-Year Est. Return
85.52%
This Fund
S&P 500
This Quarter
Est. Return
+71.62%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.25B
AUM Growth
+$397M
(+47%)
Cap. Flow
+$58M
Cap. Flow
% of AUM
4.64%
Top 10 Holdings %
Top 10 Hldgs %
51.06%
Holding
171
New
21
Increased
21
Reduced
27
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$75.2M |
| 2 |
PG&E
PCG
|
+$34.7M |
| 3 |
ARYBU
ARYA Sciences Acquisition Corp II Unit
ARYBU
|
+$7.69M |
| 4 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$7.58M |
| 5 |
VYNE Therapeutics
VYNE
|
+$6.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wayfair
W
|
+$29.2M |
| 2 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$26.5M |
| 3 |
Hycroft Mining Holding Corp
HYMC
|
+$17.7M |
| 4 |
DuPont de Nemours
DD
|
+$16.3M |
| 5 |
Angi Inc
ANGI
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 19.87% |
| 2 | Consumer Discretionary | 19.31% |
| 3 | Healthcare | 17.71% |
| 4 | Financials | 5.58% |
| 5 | Consumer Staples | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
1
People Inc
PPLI
$3.1B
| $166M | 13.28% |
2,870,724
+1,692,611
| +144% | +$75.2M |
|
2
Carvana
CVNA
$43.3B
| $165M | 13.21% |
6,867,115
-450,000
| -6% | -$8.43M |
|
3
Cardlytics
CDLX
$21M
| $59.9M | 4.8% |
85,661
-1,000
| -1% | -$577K |
|
|
NKLA
4
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
| $58.7M | 4.7% |
+28,977
| New | +$27.9M |
|
5
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $43.7M | 3.5% |
+400,000
| New | +$41.4M |
|
6
Amazon
AMZN
$2.5T
| $33.1M | 2.65% |
240,000
| – | – |
|
7
Capital One
COF
$124B
| $30.8M | 2.46% |
491,617
-64,200
| -12% | -$4M |
|
|
8
PG&E
PCG
$47.8B
| $28.2M | 2.26% |
3,183,216
+3,183,116
| +3,183,116% | +$34.7M |
|
9
CALL
Tesla
TSLA
$1.24T
| $27M | 2.16% |
375,000
| – | – |
|
10
Diageo
DEO
$46.2B
| $25.5M | 2.04% |
190,000
+15,000
| +9% | +$2.06M |
|
|
NKLA
11
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $25.3M | 2.03% |
+12,503
| New | +$12.1M |
|
12
PUT
Ventas
VTR
$48.9B
| $22M | 1.76% |
600,000
| – | – |
|
13
uniQure
QURE
$2.68B
| $21.6M | 1.73% |
480,000
-10,000
| -2% | -$591K |
|
|
EIGR
14
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $20.7M | 1.66% |
71,895
+3,895
| +6% | +$1.15M |
|
15
Adient
ADNT
$1.6B
| $19.8M | 1.58% |
1,203,588
-50,000
| -4% | -$760K |
|
16
CALL
General Motors
GM
$74.7B
| $19M | 1.52% |
750,000
| – | – |
|
17
PUT
Gaotu Techedu
GOTU
$372M
| $18M | 1.44% |
+300,000
| New | +$11.9M |
|
18
Altria Group
MO
$122B
| $17.8M | 1.43% |
453,860
-70,000
| -13% | -$2.73M |
|
19
Enova International
ENVA
$5.91B
| $17.1M | 1.37% |
1,148,058
+50,119
| +5% | +$697K |
|
|
AFMD
20
DELISTED
Affimed
AFMD
| $16.8M | 1.35% |
365,000
+215,000
| +143% | +$5.98M |
|
21
Immatics
IMTX
$1.24B
| $16.5M | 1.32% |
1,050,000
+50,000
| +5% | +$614K |
|
22
Alnylam Pharmaceuticals
ALNY
$36.3B
| $15.6M | 1.24% |
105,000
-65,000
| -38% | -$8.76M |
|
|
B
23
Barrick Mining
B
$62.2B
| $15.1M | 1.21% |
561,477
+50,000
| +10% | +$1.25M |
|
24
Syndax Pharmaceuticals
SNDX
$1.84B
| $15.1M | 1.21% |
1,016,371
+83,333
| +9% | +$1.27M |
|
25
Ardelyx
ARDX
$1.24B
| $14.9M | 1.19% |
2,154,184
| – | – |
|
Similar funds
QOP
RIL
MC
RCAG
BOH
DCM
CC
IAN
683 Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, 683 Capital Management held 171 positions worth $1.25B, up 47% from $853M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
683 Capital Management deployed $58M of net new capital in Q2 2020, opening 21 new positions and adding to 21 existing holdings. Its largest new stake was ARYA Sciences Acquisition Corp II Unit: 700,000 shares worth $8.12M.
By sector, the portfolio is most concentrated in Communication Services at 20% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Wayfair, an estimated $29.2M trimmed.
- 683 Capital Management's largest Q2 2020 buy was ARYA Sciences Acquisition Corp II Unit: 700,000 shares worth $8.12M.
- 683 Capital Management added most to People Inc in Q2 2020, an estimated $75.2M increase.
- 683 Capital Management's biggest Q2 2020 reduction was Wayfair, cutting an estimated $29.2M.
- 683 Capital Management fully exited Nikola Corporation Common Stock in Q2 2020, selling an estimated $7.23M.
- 683 Capital Management's ten largest holdings make up 51% of its $1.25B portfolio in Q2 2020.
- 683 Capital Management opened 21 new positions and closed 26 in Q2 2020.
- 683 Capital Management's portfolio value rose 47% quarter-over-quarter to $1.25B.
Based on 683 Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.